A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines
Clinical trial NCT06199336 · COMPLETED
Trial details
- NCT number
- NCT06199336
- Sponsor
- JHM BioPharma (Tonghua) Co. , Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-19
- Primary completion
- 2024-09-09
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.